Series B startup

Who invested in AnHeart Therapeutics

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$61Mraised across 1 round since 2021, from 1 source

Latest round
Series B, $61MDec 2021
Investors
2
See who backed them

The rounds

  1. Dec 2021
    Series B$61M

    Source recorded

Everyone who backed them

Vertex VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists AnHeart Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Decheng CapitalVC firmPer its own site

Quick answers about AnHeart Therapeutics

Who invested in AnHeart Therapeutics?

AnHeart Therapeutics's investors include Vertex Ventures and Vertex Ventures China.

How much has AnHeart Therapeutics raised?

AnHeart Therapeutics has raised $61M across 1 round since 2021.

When did AnHeart Therapeutics last raise?

AnHeart Therapeutics's most recent round was a Series B of $61M in Dec 2021.

What was AnHeart Therapeutics's biggest round?

Its most recent round, $61M in Dec 2021, is also its largest on record.

Who backed AnHeart Therapeutics first?

AnHeart Therapeutics's first round on record, in Dec 2021, was backed by Vertex Ventures and Vertex Ventures China.

What stage is AnHeart Therapeutics at?

AnHeart Therapeutics's latest named round is a Series B, in Dec 2021.

Companies like AnHeart Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.